Iron Monitoring in Cancer Survivors - Clinician Survey
- 09 September 2016
Iron Overload is increasingly recognised as a possible complication for cancer survivors who have received multiple blood transfusions during their cancer treatment. FerriScan can reliably and accurately screen for Iron Overload in cancer survivors with a history of blood transfusions, overcoming the poor sensitivity and specificity of serum ferritin and avoiding reliance on transfusion records, which can be incomplete.
Video Launch: "FerriScan - the Gold Standard in Liver Iron Measurement"
- 14 June 2016
Resonance Health proudly presents our new video "FerriScan - the Gold Standard in Liver Iron Measurement"....
Conference Showcase - April & May 2016
- 01 June 2016
RESONANCE HEALTH MAKING A DIFFERENCE
Our team has had a busy couple of months with attendance at seven key conferences, globally.
Perth Biotech Pioneer Receives International Award
- 13 May 2016
Resonance Health is delighted to announce that Chief Scientific Officer Professor Tim St Pierre has received the Panos Englezos Award from the Thalassaemia International Federation (TIF). This award is in recognition of the contribution made by FerriScan®, the MRI-based measurement of liver iron concentration (LIC), to the lives of patients worldwide.
Resonance Health News - March 2016
- 31 March 2016
We are happy to provide you with an update of our recent and upcoming activities in our first quarterly newsletter for 2016.
Please click here to read our latest news.
- 30 March 2016
Resonance Health is proud to provide you with a quick snapshot of a number of relevant papers that have been recently published.